Calm.com, Inc.
9
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Wellness App for Sleep Disturbance in Hematological Cancer Patients
Role: collaborator
Digital Mindfulness for Young Adults With Type 1 Diabetes
Role: collaborator
Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases
Role: collaborator
Incentivizing Meditation App Habit Formation
Role: collaborator
Feasibility of Calm to Reduce Stress and Improve Sleep During Pregnancy
Role: lead
Project Movement/Daily Move Feasibility
Role: lead
Development of Calm for Cancer Prototype Mobile App
Role: lead
Meditation for Burnout in PA Students
Role: collaborator
Feasibility of a Mobile App on Sleep
Role: collaborator
All 9 trials loaded